Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study

Introduction The use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by immune-related adverse events (irAEs). The safety profile of ICIs lacks patient experience and perspectives. This study primarily aims to obtain a...

Full description

Bibliographic Details
Main Authors: Takuhiro Yamaguchi, Tempei Miyaji, Takashi Kawaguchi, Kanako Azuma, Taiki Hirata, Ayako Torii, Hiroaki Usui, Soan Kim, Tatsuya Hayama, Daisuke Hirate, Yosuke Kawahara, Yuki Kumihashi, Tomomi Chisaka, Tetsuya Wako, Akinobu Yoshimura
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/11/e073724.full

Internet

https://bmjopen.bmj.com/content/13/11/e073724.full

Similar Items